Menu
Back to Journals » OncoTargets and Therapy » Volume 14
Case report
Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,765 | Dovepress* | 4,213+ | 626 | 4,839 | |
| PubMed Central* | 552 | 164 | 716 | ||
| Totals | 4,765 | 790 | 5,555 | ||
| *Since 7 May 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 1 | 1 | 2 |
View citations on PubMed Central and Google Scholar